Literature DB >> 1979509

Chronic beta 1-adrenoceptor antagonist treatment sensitizes beta 2-adrenoceptors, but desensitizes M2-muscarinic receptors in the human right atrium.

S Motomura1, N M Deighton, H R Zerkowski, N Doetsch, M C Michel, O E Brodde.   

Abstract

1. In 64 patients undergoing coronary artery bypass grafting the effects of chronic beta 1-adrenoceptor antagonist (metoprolol, atenolol, bisoprolol) treatment on right atrial beta-adrenoceptor and muscarinic M2-receptor number and functional responsiveness were investigated. 2. The beta 1-adrenoceptor antagonists increased right atrial beta 1-adrenoceptor number, did not affect beta 2-adrenoceptor number, and decreased muscarinic M2-receptor number. 3. Concomitantly, activation of right atrial adenylate cyclase by 10 microM GTP, 10 microM isoprenaline and 1 microM forskolin was enhanced and inhibition by 100 microM carbachol was diminished. 4. On isolated, electrically driven right atria the beta 1-adrenoceptor-mediated positive inotropic effect of noradrenaline was - even with beta 1-adrenoceptor number increased - not altered, while the beta 2-adrenoceptor-mediated effect of procaterol was markedly enhanced. However, the carbachol-induced negative inotropic effect was decreased. 5. It is concluded that chronic beta 1-adrenoceptor antagonist treatment increases beta 1-adrenoceptor number and concomitantly sensitizes beta 2-adrenoceptor function, but desensitizes muscarinic M2-receptor function in the human heart.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979509      PMCID: PMC1917687          DOI: 10.1111/j.1476-5381.1990.tb12715.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

Review 1.  Beta-adrenoceptor blocking drugs in hypertension.

Authors:  A Scriabine
Journal:  Annu Rev Pharmacol Toxicol       Date:  1979       Impact factor: 13.820

2.  Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

Authors:  D G McDevitt
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

3.  Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

Authors:  G A McPherson
Journal:  J Pharmacol Methods       Date:  1985-11

4.  The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551).

Authors:  A J Bilski; S E Halliday; J D Fitzgerald; J L Wale
Journal:  J Cardiovasc Pharmacol       Date:  1983 May-Jun       Impact factor: 3.105

Review 5.  The beta-adrenergic blockade withdrawal phenomenon.

Authors:  B N Prichard; B Tomlinson; R J Walden; P Bhattacharjee
Journal:  J Cardiovasc Pharmacol       Date:  1983       Impact factor: 3.105

6.  Vagal activity is increased during intravenous isoprenaline infusion in man.

Authors:  J M Arnold; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

7.  Human cardiac beta-adrenoceptors: both beta 1- and beta 2-adrenoceptors are functionally coupled to the adenylate cyclase in right atrium.

Authors:  O E Brodde; N O'Hara; H R Zerkowski; N Rohm
Journal:  J Cardiovasc Pharmacol       Date:  1984 Nov-Dec       Impact factor: 3.105

8.  A comparison between muscarinic receptor occupancy, adenylate cyclase inhibition, and inotropic response in human heart.

Authors:  M Delhaye; J M De Smet; G Taton; P De Neef; J C Camus; J Fontaine; M Waelbroeck; P Robberecht; J Christophe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

9.  Beta-blockers in dilated cardiomyopathies: they work.

Authors:  F Waagstein; A Hjalmarson; K Swedeberg; I Wallentin
Journal:  Eur Heart J       Date:  1983-01       Impact factor: 29.983

10.  Rationale for beta-adrenergic blocking drugs in cardiomyopathy.

Authors:  M B Fowler; M R Bristow
Journal:  Am J Cardiol       Date:  1985-04-26       Impact factor: 2.778

View more
  19 in total

Review 1.  Transcriptional regulation by cAMP in the heart.

Authors:  F U Müller; J Neumann; W Schmitz
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  Short-term desensitization of the histamine H1 receptor in human HeLa cells: involvement of protein kinase C dependent and independent pathways.

Authors:  M J Smit; S M Bloemers; R Leurs; L G Tertoolen; A Bast; S W de Laat; H Timmerman
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

3.  Does treatment with beta-adrenoceptor antagonists in vivo alter human adenylate cyclase responsiveness in vitro?

Authors:  M C Michel; M Klüppel; T Philipp; O E Brodde
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

Review 4.  Adrenergic and muscarinic receptor regulation and therapeutic implications in heart failure.

Authors:  W Schmitz; P Boknik; B Linck; F U Müller
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

5.  Cross-regulation between cardiac muscarinic acetylcholine receptors and β-adrenoceptors: lessons for use of knock-out mice.

Authors:  Stefan Dhein; Sandy von Salisch; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-11-10       Impact factor: 3.000

Review 6.  Beta-adrenoceptor blocker treatment and the cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure.

Authors:  Otto-Erich Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-11       Impact factor: 3.000

7.  Chronic (-)-isoprenaline infusion down-regulates beta 1- and beta 2-adrenoceptors but does not transregulate muscarinic cholinoceptors in rat heart.

Authors:  J M Matthews; P H Falckh; P Molenaar; R J Summers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

8.  Beta 1- and beta 2-adrenoceptor-mediated relaxation in human internal mammary artery and saphenous vein: unchanged beta- and alpha-adrenoceptor responsiveness after chronic beta 1-adrenoceptor blockade.

Authors:  A Ferro; A J Kaumann; M J Brown
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

Review 9.  Some aspects of heart beta adrenoceptor function.

Authors:  A J Kaumann
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

10.  Regional distribution of beta 1- and beta 2-adrenoceptors in the failing and nonfailing human heart.

Authors:  M Steinfath; J Lavicky; W Schmitz; H Scholz; V Döring; P Kalmár
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.